Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary /
| Основен автор: | Patlak, Margie. |
|---|---|
| Автор-организация: | National Cancer Policy Forum (U.S.), United States. Department of Health and Human Services. |
| Други автори: | Nass, Sharyl J. |
| Формат: | Електронен |
| Език: | English |
| Публикувано: |
Washington, D.C. :
National Academies Press,
℗♭2006.
|
| Предмети: | |
| Онлайн достъп: |
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=178871 |
| Подобни документи: |
Print version::
Developing biomarker-based tools for cancer screening, diagnosis, and treatment. |
Съдържание:
- Cover
- Reviewers
- Contents
- Introduction
- Overview of Technologies Used to Discover Cancer Biomarkers
- Genomics, Proteomics, and Metabolomics
- Molecular Imaging
- Meeting the Technical Challenges of Biomarker Validation and Qualification
- Coordinating the Development of Biomarkers and Targeted Therapies
- Therapeutics Industry Perspective
- Diagnostics Industry Perspective
- NCI Perspective
- Clinical Investigator Perspective
- Biomarker Development and Regulatory Oversight
- FDA Critical Path Initiative
- Oversight of Diagnostic Tests
- Designing Clinical Studies of Biomarkers
- Assessment and Adoption of Biomarker-Based Technologies
- Federal Programs for Technology Assessment
- Insurance Coverage Decisions and Practice Guidelines
- CMS Coverage of Biomarkers
- Economic Impact of Biomarkers
- Cost-Effectiveness Analysis
- The Value of Information and Research
- Technology Assessment in the Private Sector
- Clinical Development Strategies for Biomarker Utilization Discussion
- Strategies for Implementing Standardized Biorepositories Discussion
- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion
- Strategies to Develop Biomarkers for Early Detection Discussion
- Mechanisms for Developing an Evidence Base Discussion
- Evaluation of Evidence in Decision Making Discussion
- Incorporating Biomarker Evidence Into Clinical Practice Discussion
- Acronyms
- Glossary
- References
- Appendixes
- Appendix A Workshop Agenda
- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants
- Last Page.